Hohenstatt, Sophia http://orcid.org/0000-0003-0951-3948
Ulfert, Christian
Herweh, Christian
Hilgenfeld, Tim
Schmitt, Niclas
Schönenberger, Silvia
Chen, Min
Bendszus, Martin
Möhlenbruch, Markus A.
Vollherbst, Dominik F.
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 9 May 2023
Accepted: 22 August 2023
First Online: 13 October 2023
Declarations
:
: C. Ulfert received consulting fees from Johnson & Johnson. C. Herweh is consultant for Brainomix. M. Bendszus reports board membership: DSMB Vascular Dynamics; consultancy: Roche, Guerbet, Codman; grants/grants pending: DFG, Hopp Foundation, Novartis, Siemens, Guerbet, Stryker, Covidien; payment for lectures (including service on speakers bureaus): Novartis, Roche, Guerbet, Teva, Bayer, Codman. M.A. Möhlenbruch has received consulting honoraria, speaker honoraria, and travel support outside this work from Balt, Codman, Covidien/Medtronic, MicroVention, Phenox, and Stryker. D.F. Vollherbst reports consultancy for Medtronic and paidlectures for Cerenovus, and a research grant by MicroVention (unrelated to this work). S. Hohenstatt, T. Hilgenfeld, N. Schmitt, S. Schönenberger and M. Chen declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.